Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1984 1
2000 1
2002 1
2003 1
2005 2
2008 1
2013 1
2015 1
2016 1
2017 1
2018 1
2021 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.
Gupta A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, Moya J, Falci DR, Sarkis E, Solis J, Zheng H, Scott N, Cathcart AL, Hebner CM, Sager J, Mogalian E, Tipple C, Peppercorn A, Alexander E, Pang PS, Free A, Brinson C, Aldinger M, Shapiro AE; COMET-ICE Investigators. Gupta A, et al. N Engl J Med. 2021 Nov 18;385(21):1941-1950. doi: 10.1056/NEJMoa2107934. Epub 2021 Oct 27. N Engl J Med. 2021. PMID: 34706189 Clinical Trial.
"Model" behavior.
Sarkis EH. Sarkis EH. Science. 2000 Mar 24;287(5461):2160-2. doi: 10.1126/science.287.5461.2159e. Science. 2000. PMID: 10744536 No abstract available.
Assessment of symptoms in COMET-ICE, a phase 2/3 study of sotrovimab for early treatment of non-hospitalized patients with COVID-19.
Satram S, Ghafoori P, Reyes CM, Keeley TJH, Birch HJ, Brintziki D, Aldinger M, Alexander E, Lopuski A, Sarkis EH, Gupta A, Shapiro AE, Powers JH 3rd. Satram S, et al. Among authors: sarkis eh. J Patient Rep Outcomes. 2023 Sep 13;7(1):92. doi: 10.1186/s41687-023-00621-8. J Patient Rep Outcomes. 2023. PMID: 37702920 Free PMC article. Clinical Trial.
A 6-Month Open-Label Extension Study of Vortioxetine in Pediatric Patients with Depressive or Anxiety Disorders.
Findling RL, Robb AS, DelBello MP, Huss M, McNamara NK, Sarkis EH, Scheffer RE, Poulsen LH, Chen G, Lemming OM, Auby P. Findling RL, et al. Among authors: sarkis eh. J Child Adolesc Psychopharmacol. 2018 Feb;28(1):47-54. doi: 10.1089/cap.2017.0047. Epub 2017 Oct 16. J Child Adolesc Psychopharmacol. 2018. PMID: 29035574 Free PMC article. Clinical Trial.
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adults With Attention-Deficit/Hyperactivity Disorder.
Faraone SV, Childress A, Caras S, Arnold VK, Montano CB, Sarkis EH, Cutler AJ, Young JL. Faraone SV, et al. Among authors: sarkis eh. J Clin Psychiatry. 2021 Aug 24;82(5):21m13927. doi: 10.4088/JCP.21m13927. J Clin Psychiatry. 2021. PMID: 34428356 Clinical Trial.
Sinus region electrograms.
Asseman P, Berzin B, Desry D, Vilarem D, Durand P, Sarkis EH, Thery C, Lekieffre J. Asseman P, et al. Among authors: sarkis eh. Circulation. 1983 May;67(5):1159-60. doi: 10.1161/01.cir.67.5.1159. Circulation. 1983. PMID: 6831678 No abstract available.
Compliance with FDA recommendations for pemoline.
Sarkis EH. Sarkis EH. J Am Acad Child Adolesc Psychiatry. 2003 Apr;42(4):383; author reply 383. doi: 10.1097/01.CHI.0000037045.04952.A0. J Am Acad Child Adolesc Psychiatry. 2003. PMID: 12649623 No abstract available.
GW320659 for the treatment of attention-deficit/hyperactivity disorder in children.
DeVeaugh-Geiss J, Conners CK, Sarkis EH, Winner PK, Ginsberg LD, Hemphill JM, Laurenza A, Barrows CE, Webster CJ, Stotka CJ, Asgharnejad M. DeVeaugh-Geiss J, et al. Among authors: sarkis eh. J Am Acad Child Adolesc Psychiatry. 2002 Aug;41(8):914-20. doi: 10.1097/00004583-200208000-00009. J Am Acad Child Adolesc Psychiatry. 2002. PMID: 12162627
17 results